Regeneron (REGN) Stock Price

$547.8 1.8%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    6

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Regeneron, AI stock picks, stock alerts and much more.

Sign up

REGN AI Stock Analysis

AI stock analysis for REGN is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron (REGN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Regeneron (REGN) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron (REGN), currently trading at $547.8, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About REGN

LSE

  • Regeneron Pharmaceuticals, Inc.

  • Symbol

    REGN

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    58.1B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $20.75
1%
6
INO Inovio Pharmaceuticals
INO		 $1.34
0.8%
3
MRNA Moderna
MRNA		 $32.54
8.8%
3
AVXL Anavex Life Sciences
AVXL		 $10.19
2%
6
BBIO BridgeBio Pharma
BBIO		 $43.19
0.7%
7

News

FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug

FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug
July 3, 2025. zacks.com
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
June 26, 2025. globenewswire.com
Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade

Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade
June 25, 2025. seekingalpha.com
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization

Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
June 24, 2025. globenewswire.com

REGN Alternative Data

Web Traffic

Regeneron receives an estimated 319793 monthly visitors to regeneron.com.

  • Web Traffic

    319793

  • Change from Previous Month

    16.6%

  • 3 Month Change

    10.1%

  • YoY Change

    10.1%

Twitter Followers

Regeneron has 33,276 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.

  • Twitter Followers

    33276

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.9%

  • YoY Change

    0.9%

Facebook Engagement

Regeneron has engaged 1,229 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1229

  • Daily Change

    8.4%

  • 1 Month Change

    13.3%

  • 3 Month Change

    8.7%

  • YoY Change

    8.7%

Instagram Followers

Regeneron has 16,465 Instagram Followers on its main Instagram account, up by 1.2% over the last month.

  • Instagram Followers

    16465

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    12.6%

  • YoY Change

    12.6%

LinkedIn Followers

558,730 are following Regeneron on LinkedIn, up by 1.4% over the last month.

  • LinkedIn Followers

    558730

  • Daily Change

    0.1%

  • 1 Month Change

    1.4%

  • 3 Month Change

    4.8%

Job Postings

Regeneron has an estimated 295 open job postings, which is down -3.9% over the last month.

  • Job Postings

    295

  • Daily Change

    3%

  • 1 Month Change

    3.9%

  • 3 Month Change

    10.1%

  • YoY Change

    10.1%

LinkedIn Employees

According to LinkedIn, Regeneron has 16,340 employees, up by 1.2% over the last month.

  • LinkedIn Employees

    16340

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.4%

  • YoY Change

    3.4%

Reddit Mentions

Regeneron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Regeneron is 71 out of 100 (bullish), down by -1.4% over the last month.

  • Business Outlook

    71

  • Change from Previous Month

    1.4%

  • 3 Month Change

    6.6%

  • YoY Change

    6.6%

Reddit Sentiment

The sentiment Score for Regeneron is 53 out of 100, which represents a neutral sentiment.

  • Reddit Sentiment

    52.5714

  • Daily Change

    22.5%

  • 1 Month Change

    0%

News Mentions

Regeneron was mentioned 5 times in the news yesterday.

  • News Mentions

    5

  • Daily Change

    25%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

REGN Financials

REGN Key Metrics

  • Total Revenue

    $3B

  • Net Income

    $808.7M

  • Earnings per Share

    $7.58

  • Free cash flow

    $773.6M

  • EBITDA

    $1B

  • EBITDA Ratio

    0.34358

  • Total Assets

    $37.5B

REGN 2-year Revenue & Income
REGN 2-year Free Cash Flow

REGN Technicals

REGN SMA
REGN RSI

FAQ

What's the current price of Regeneron (REGN) Stock?
The price of an Regeneron (REGN) share is $547.8.

What's the market cap of Regeneron?
The current market cap of Regeneron is 58.1B.

Should I buy or sell REGN?
Regeneron shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Regeneron is better viewed as a hold or accumulate position while waiting for further developments.

Is Regeneron a good investment?
The current analysis of Regeneron's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Regeneron's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Regeneron (REGN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Regeneron stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Regeneron (REGN) that investors often compare it to?
Regeneron (REGN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Regeneron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron's stock price to be around $575.4 in 2026. Starting from the current price of $547.8, this represents a 5% change in price, indicating a bullish outlook for the stock.

How to buy Regeneron (REGN) Stock?
Regeneron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.